Injective (INJ) rebounds to $14.16 (+1.22%) despite challenges, with $100M investment from Pineapple Financial. Bullish trend noted.

The stock for INJ is currently trading at $14.16, reflecting a positive increase of 1.22%. This surge comes in the wake of Pineapple Financial injecting a substantial $100 million investment into the company. Despite facing regulatory challenges recently, technical analysis indicates a strong bullish trend in the market, showcasing the resilience of INJ amidst external pressures.